Procalcitonin Testing and Molecular Pathogen Detection: A Value Model

 

Procalcitonin Testing and Molecular Pathogen Detection

Nam K. Tran, PhD, FACB, shows what it takes to design and implement a successful antimicrobial stewardship program in an acute care hospital setting. During this informative and enlightening presentation, Dr. Tran also reviews the new regulatory requirements for antimicrobial stewardship, and shares with you how procalcitonin and molecular point-of-care diagnostic testing can be used effectively to help reduce unnecessary antimicrobial use. He also discusses how to establish antimicrobial stewardship metrics.

 

Previous Article
Can (and Should) Non-MD Experts Lead a DMT?
Can (and Should) Non-MD Experts Lead a DMT?

The most effective DMTs incorporate input from MDs, PhDs, pathologists, lab leaders and other departments.

Next Article
Is It or Isn’t It a DMT?
Is It or Isn’t It a DMT?

How to determine whether or not your advisory group meets Diagnostic Management Team criteria